Accessibility Menu
 
Cresco Labs logo

Cresco Labs

(OTC) CRLBF

Current Price$0.84
Market Cap$323.85M
Since IPO (2018)-79%
5 Year-93%
1 Year+19%
1 Month-12%

Cresco Labs Financials at a Glance

Market Cap

$323.85M

Revenue (TTM)

$658.33M

Net Income (TTM)

$138.14M

EPS (TTM)

$-0.38

P/E Ratio

-2.38

Dividend

$0.00

Beta (Volatility)

0.85 (Low)

Price

$0.84

Volume

905,653

Open

$0.89

Previous Close

$0.84

Daily Range

$0.81 - $0.94

52-Week Range

$0.43 - $2.30

CRLBF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cresco Labs

Industry

Pharmaceuticals

Employees

2,900

CEO

Charles Bachtell

Headquarters

Chicago, IL 60654, US

CRLBF Financials

Key Financial Metrics (TTM)

Gross Margin

49%

Operating Margin

10%

Net Income Margin

-21%

Return on Equity

-33%

Return on Capital

6%

Return on Assets

-12%

Earnings Yield

-42.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$323.85M

Shares Outstanding

360.03M

Volume

905.65K

Short Interest

0.00%

Avg. Volume

970.76K

Financials (TTM)

Gross Profit

$309.72M

Operating Income

$78.46M

EBITDA

$128.03M

Operating Cash Flow

$74.17M

Capital Expenditure

$35.75M

Free Cash Flow

$38.41M

Cash & ST Invst.

$90.92M

Total Debt

$583.10M

Cresco Labs Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$164.04M

-6.0%

Gross Profit

$79.56M

-3.6%

Gross Margin

48.50%

N/A

Market Cap

$323.85M

N/A

Market Cap/Employee

$111.67K

N/A

Employees

2,900

N/A

Net Income

$90.32M

-1965.8%

EBITDA

$29.12M

-10.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$492.18M

+2.0%

Accounts Receivable

$38.94M

-24.5%

Inventory

$0.00

-100.0%

Long Term Debt

$560.09M

-9.1%

Short Term Debt

$23.06M

-2.1%

Return on Assets

-11.56%

N/A

Return on Invested Capital

6.00%

N/A

Free Cash Flow

$18.72M

-28.0%

Operating Cash Flow

$27.88M

-5.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HLOSFHealios K.K.
$2.70+0.00%
NWBONorthwest Biotherapeutics, Inc.
$0.20-1.95%
PTCHFPureTech Health plc
$1.55-14.84%
AVCTFAvacta Group Plc
$0.87-5.26%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About CRLBF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.